Clinical Trial

Therapeutic Exposures and Risk Factors in MRONJ

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 28, 2024 (before its estimated April 25, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study focuses on patients who have developed a condition called medication-related osteonecrosis of the jaw (MRONJ), which can occur after using certain medications. The purpose is to closely monitor these patients over time to better understand how they are diagnosed, treated, and followed up. By doing this, researchers hope to uncover how different factors such as a patient's background, lifestyle, and other health conditions might influence their recovery and overall quality of life.
Trial Details
NCT Number NCT06430762
Lead Sponsor Marmara University
Conditions Medication-Related Osteonecrosis of Jaw
Enrollment 250 participants
Start Date 2024-04-25
Primary Completion 2026-04-25 (estimated)
Study Completion 2027-04-26 (estimated)
Updated on ClinicalTrials.gov 2024-05-28